AxoGen,: Submission Of Matters To A Vote Of Security Holders


The following excerpt is from the company's SEC filing.

On May 13, 2014, AxoGen, Inc. (the “Company”) held its 2014 Annual Meeting of Shareholders (the “Meeting”). The matters voted on by shareholders at the Meeting included (1) a proposal to elect eight (8) Directors to serve until the next Annual Meeting of Shareholders and until their respective successors shall have been duly elected and qualified, (2) a proposal to approve an amendment and restatement of the AxoGen 2010 Stock Incentive Plan (the “Plan”) to increase the number of shares of common stock of AxoGen authorized for issuance under the Plan from 2,750,000 to 3,500,000; and (3) a proposal to ratify the appo intment of Lurie Besikof Lapidus & Company, LLP (“LBL”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014. There were represented at the Meeting, either in person or by proxy, 14,397,248 shares of the Company’s common stock, out of a total number of 17,445,968 shares of the Company’s common stock outstanding and entitled to vote at the Meeting. The results of the shareholders’ votes are as follows:

Proposal No. 2:         Approve an amendment and restatement of the Plan to increase the number of shares of common stock of AxoGen authorized for issuance under the Plan from 2,750,000 to 3,500,000.:

The foregoing votes reflect that the proposals received the requisite votes to (i) elect all eight (8) of the nominees of the Board of Directors, (ii) approve the amendment and restatement of the Plan to increase the number of shares of common stock of AxoGen authorized for issuance under the Plan from 2,750,000 to 3,500,000; and (iii) ratify the appointment of LBL as the Company’s independent public accounting firm for the fiscal year ending December 31, 2014.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.

To receive a free e-mail notification whenever AxoGen, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

AxoGen, Inc.'s Chief Financial Officer just picked up 10,000 shares - Dec. 11, 2014
Confidential treatment order - Dec. 8, 2014
AxoGen, Inc. director just picked up 6,000 shares - Dec. 3, 2014
AxoGen, Inc. just filed a General Statement of acquisition of beneficial ownership - Nov. 24, 2014

   Auto Refresh

Feedback